Moreover, as a functional biomarker, CD10 promises to have clinical relevance and diverse applications for drug screening, differentiation assessment, and therapeutics related to obesity and diabetes. This evidence concerns the gene MME and obesity due to melanocortin 4 receptor deficiency.